NCT05793372View on ClinicalTrials.gov

Hyperhomocysteinemia in Alzheimer's Disease

Not yet recruitingOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

June 30, 2023

Study Completion Date

March 1, 2026

Conditions
Alzheimer DiseaseHomocystinemia
Interventions
OTHER

Retrospective study of clinical features

Retrospective study of clinical features

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT05793372 - Hyperhomocysteinemia in Alzheimer's Disease | Biotech Hunter | Biotech Hunter